Fluorescent sterols monitor cell penetrating peptide Pep-1 mediated uptake and intracellular targeting of cargo protein in living cells  by Petrescu, Anca D. et al.
Biochimica et Biophysica Acta 1788 (2009) 425–441
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemFluorescent sterols monitor cell penetrating peptide Pep-1 mediated uptake and
intracellular targeting of cargo protein in living cells
Anca D. Petrescu b, Aude Vespa b, Huan Huang b, Avery L. McIntosh b, Friedhelm Schroeder b, Ann B. Kier a,⁎
a Department of Pathobiology, Texas A and M University, TVMC, College Station, TX 77843-4467, USA
b Department of Physiology and Pharmacology Texas A and M University, TVMC College Station, TX 77843-4467, USAAbbreviations: ACBP, acyl coenzyme A binding prote
DHE, dehydroergosterol; LUV, large unilamellar vesicles
CD, circular dichroism; LSCM, laser scanning confocal mic
laser scanning microscopy
⁎ Corresponding author. Tel.: +1 979 862 1509; fax: +
E-mail address: akier@cvm.tamu.edu (A.B. Kier).
0005-2736/$ – see front matter © 2008 Elsevier B.V. Al
doi:10.1016/j.bbamem.2008.09.015a b s t r a c ta r t i c l e i n f oArticle history: Although cell-penetrating p
Received 26 June 2008
Received in revised form 25 August 2008
Accepted 24 September 2008
Available online 17 October 2008
Keywords:
Acyl-CoA binding protein
Confocal microscopy
Dansyl-cholestanol
Dehydroergosterol
Endocytosis
Macropinocytosis
Multiphoton excitationeptides (CPP) facilitate endocytic uptake of proteins, little is known regarding the
extent to which CPPs facilitate protein cargo exit from endocytic vesicles for targeting to other intracellular
sites. Since the plasma membrane and less so intracellular membranes contain cholesterol, the ﬂuorescent
sterol analogues dansyl-cholestanol (DChol) and dehydroergosterol (DHE) were used to monitor the uptake
and intracellular distribution of ﬂuorescent-tagged acyl coenzyme A binding protein (ACBP) into COS-7 cells
and rat hepatoma cells. Confocal microscopy colocalized DChol and Texas Red-ACBP (TR-ACBP) with markers
for the major endocytosis pathways, especially ﬂuorescent-labeled cholera toxin (marker of ganglioside GM1
in plasma membrane lipid rafts) and dextran (macropinocytosis marker), but less so with transferrin
(clathrin-mediated endocytosis marker). These ﬁndings were conﬁrmed by multiphoton laser scanning
microscopy colocalization of TR-ACBP with DHE (naturally-ﬂuorescent sterol) and by double immunoﬂuor-
escence labeling of native endogenous ACBP. Serum greatly and Pep-1 further 2.4-fold facilitated uptake of
TR-ACBP, but neither altered the relative proportion of TR-ACBP colocalized with membranes/organelles
(nearly 80%) vs cytoplasm and/or nucleoplasm (20%). Interestingly, Pep-1 selectively increased TR-ACBP
associated with mitochondria while concomitantly decreasing that in endoplasmic reticulum. In summary,
ﬂuorescent sterols (DChol, DHE) were useful markers for comparing the distributions of both transported and
endogenous proteins. Pep-1 modestly enhanced the translocation and altered the intracellular targeting of
exogenous-delivered (TR-ACBP) in living cells.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The cell surface membrane functions as a barrier preventing
passive entry of xenobiotics, proteins, antibodies, drugs, toxins, DNA,
RNA, and living microorganisms. However, therapeutics increasingly
requires delivery of biologically active macromolecule cargoes into
cells (rev. in [1]. While microinjection or electroporation bypass the
endocytosis/lysosomal degradative pathway to deliver active macro-
molecules into cells, these methods are invasive, exhibit low
efﬁciency, poor speciﬁcity, and toxicity (rev. in [1–3]. Therefore,
increasing interest has focused on the use of specialized cell
penetrating peptides (CPP) to facilitate macromolecule (cargo) entry
into cells (rev. [1,3–6]. CPPs evolved as small polypeptide regions of
certain proteins enabling them to circumvent the plasma membrane
barrier to gain entry into the cell and exert their biological effects.in; DChol, dansyl-cholestanol;
; CPP, cell penetrating peptide;
roscopy;MPLSM,multiphoton
1 979 862 9231.
l rights reserved.The mechanism(s) whereby CPPs and CPP-mediated cargo are
translocated through biological membranes is a very active, con-
troversial area of investigation (rev. in [4,5]. CPP transduction and CPP-
mediated cargo transduction through the cell surface membrane was
originally thought to be non-saturable, dose-dependent, temperature-
independent, and energy independent — thereby excluding endocy-
tosis (rev. in [1,4–6]. However, subsequent investigations showed that
some of the early conclusions were complicated by experimental
artifacts (rev. in [1,7]. Instead many CPPs, especially those covalently
attached to cargo proteins, are taken up and facilitate cargo uptake
into living cells via one or more of the well-known endocytic routes
including clathrin-coated vesicles, lipid rafts, caveolae, or macro-
pinocytosis (rev. in [1,3–6,8–10]. Interestingly, it was recently reported
that endocytosis inhibitors clearly reduced the Pep-1 (non-covalently
attached to cargo protein) mediated translocation efﬁciency of
ﬂuorescent labeled β-galactosidase into HeLa cells but did not result
in colocalization with endosomes, lysosomes, or caveosomes in ﬁxed
HeLa cells [11,12]. Taken together, these data suggest that non-
covalently attached CPPs such as Pep-1 may facilitate both endocytic
and non-endocytic uptake of cargo protein [2,12,13].
Despite the above advances, however, it is not clear whether the
CPPs such as Pep-1 not only facilitate endocytic entry of non-
426 A.D. Petrescu et al. / Biochimica et Biophysica Acta 1788 (2009) 425–441covalently bound cargo protein but also enhance cargo protein exit
from endocytic vesicles into the cytoplasm of cells. In fact, almost
nothing is known about the proportion of CPP cargo that actually
enters the cytoplasm. The fact that CPPmediated protein transduction
does elicit functional responses in living cells clearly suggests that at
least some of the translocated protein enters the cytoplasm for
targeting cellular functions [7,8,14,15]. However, it is not known
whether this represents a minority or a signiﬁcant proportion of cargo
protein exit from endocytic pathways, entry into cytoplasm, and
correct redistribution to intracellular organelles in a manner similar to
the respective endogenous protein (rev. in [1,3–6].
The current investigation was undertaken to develop the use of
ﬂuorescent sterols (DChol and DHE) as markers for exogenous protein
translocation and association of both exogenous and endogenous
protein with membranes and endocytosed plasma membrane
vesicles. The ﬂuorescent sterols were chosen as membrane markers
because, with the exception of the inner mitochondrial membrane, all
mammalian membranes contain signiﬁcant amounts of cholesterol
ranging from as much as 50% of total lipid (plasma membrane) to
about 20% of total lipid (endoplasmic reticulum) (rev. in [16–20]. ACBP
was chosen as a model cargo protein because of its small size (10 kDa),
distribution throughout the cytoplasm, association with select
organelles, and ability to pass through nuclear pores (too small to
accommodate endocytic vesicles) into the nucleoplasm for interaction
with nuclear receptors (rev. in [21,22]. The results showed that the
ﬂuorescent sterols (DChol, DHE) were useful markers comparing the
distributions of both transported and endogenous proteins. While
Pep-1 did not alter the relative proportions of membrane vs cytosol/
nucleoplasm associated TR-ACBP, Pep-1 modestly enhanced the
translocation and altered the intracellular targeting of exogenous-
delivered (TR-ACBP) by shifting TR-ACBP distribution away from
endoplasmic reticulum toward mitochondria.
2. Materials and methods
2.1. Materials
Pep-1 (Chariot™) was obtained from Active Motif (Rikensart,
Belgium). Ni-CAM resin and protease inhibitor cocktail were pur-
chased from Sigma, St-Louis, MO. BioGel P4 resin was from Bio-Rad
(Hercules, CA). Two-well LabTek coverglasses, from VWR (Sugarland,
TX). BCA protein assay kit was from Pierce Biotechnology Inc.
(Rockford, IL). COS-7 cells were obtained from the American Type
Culture Collection (Manassas, VA). 1-Palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidylcholine (POPC) was from Avanti Polar Lipids (Alabaster,
AL). Cis-parinaric acid (naturally-ﬂuorescent fatty acid) was obtained
from Molecular Probes, Invitrogen (Eugene, OR). Cis-parinaroyl-CoA
(natural-ﬂuorescent fatty acyl CoA) was synthesized as described
earlier [23]. Vital dye markers for plasma membrane and intracellular
membrane organelles were obtained from Molecular Probes, Invitro-
gen (Eugene, OR) as follows: Alexa Fluor 488 (CT-488) and 594 (CT-
594) cholera toxin subunit B (CT-B) conjugates (markers for ganglio-
side GM1 present in plasma membrane lipid rafts), Texas Red-dextran
(marker for macropinocytosis), Texas Red-transferrin (marker for
clathrin-coated pits and vesicles), LysoTracker Yellow-HCK123 (mar-
ker for lysosomes), ER-Tracker Green (i.e. glibenclamide BODIPY-FL)
(marker for endoplasmic reticulum), NBD-C6-ceramide (marker for
Golgi complex), MitoFluor Green (marker for mitochondria), and
Hoechst 33342 (marker for nucleus). Texas Red–X succinimidyl ester
was purchased from Molecular Probes (Invitrogen Life Technologies,
Carlsbad, CA) while Cy5 labeling kit was from Amersham Biosciences
Corp. ( Piscataway, NJ). Antibodies to membrane organelle markers for
ﬁxed cells were purchased as follows: anti-cathepsin D antibody
(Sigma Chemical Co., St. Louis, MO), anti-mitochondrial HSP70
antibody (Afﬁnity Bioreagents, Inc., Golden, CO), and Texas Red- and
FITC- anti-rabbit, anti-rat, anti-mouse IgGs (Molecular Probes,Invitrogen, Eugene, OR). Concanavalin-FITC (ER marker of ﬁxed cells)
and wheat germ agglutinin-FITC (Golgi marker of ﬁxed cells) were
obtained from Sigma (St. Louis, MO). Dulbecco modiﬁed Eagle's
medium (DMEM), fetal bovine serum (FBS), phosphate saline buffer
(PBS) and Hank's solutions were from Invitrogen (Carlsbad, CA).
2.2. Expression and puriﬁcation of recombinant of acyl CoA binding
protein (ACBP)
C-terminal histidine tagged recombinant mouse ACBP was
expressed in E. coli BL21 cells from a pET21b vector under IPTG
induction, and puriﬁed by afﬁnity chromatography on Ni-CAM resin as
described [24]. Protein concentration was determined in each elution
fraction by BCA assay. Purity of his-ACBP was assessed by SDS-PAGE in
14% acrylamide gels according to a Bio-Rad procedure [25] followed by
Coomassie blue staining. His-ACBP appeared as a single band at the
expected molecular weight near 11 kDa. Western blotting of his-ACBP
was performed to conﬁrm identity by using locally-produced rabbit
polyclonal antiserum raised against native rat liver ACBP, as previously
described [22].
2.3. Labeling of recombinant ACBP protein with ﬂuorescent dyes: Texas
Red and Cy5
The surface of ACBP exhibits 7 exposed amino acid residues with
free amino groups [26]. Therefore, His-ACBP was covalently labeled
with the ﬂuorescent tag Texas Red by use of a Texas Red-X
succinimidyl ester labeling kit from Molecular Probes/Invitrogen
(Eugene, OR) or by use of a Cy5 labeling kit from Amersham
Biosciences Corp. (Piscataway, NJ) according to the manufacturers'
instructions. To minimize the number of dye/ACBP protein molecule,
generally 0.5 mg his-ACBP was incubated with dye/DMSO in a 1:5
protein/dye molar ratio, in phosphate buffer saline (PBS), pH 8.5, with
stirring for 1 h at room temperature. After removing possible
aggregates by a brief centrifugation at 20,000 ×g , the dye/protein
conjugate was isolated from unreacted dye by gel-exclusion chroma-
tography on BioGel P4 resin. Qualitative determination of ﬁnal dye-
labeled ACBP products were performed by SDS-PAGE and Western
blotting. The molecular size of dye-his-ACBP conjugates and dye-to-
protein molar ratios were determined by matrix assisted laser
desorption mass spectrometry (MALDI) performed at the Texas A&M
University Mass Spectrometry Laboratory.
2.4. Circular dichroism (CD) analysis of dye-labeled ACBP as compared to
unlabeled ACBP recombinant protein
To assure that covalent labeling of his-ACBP with ﬂuorescent tags
(TR, Cy5) did not alter his-ACBP structure, far ultraviolet (UV) circular
dichroic (CD) spectra of Texas Red- and Cy5-labeled, recombinant
mouse ACBP and unlabeled-ACBP were measured in 30 mM phos-
phate buffer, pH 7.4 using a J-710 spectropolarimeter (Jasco, Baltimore,
MD) and 1 mm cuvette as described earlier [24]. Spectra were
recorded from 260 to 190 nm at 50 nm/min, with integration time of
1 s and a bandwidth of 2 nm. An average of 10 scans were run for each
CD proﬁle. Percentage composition of secondary structures was
calculated by using CDPRO software as described [27].
2.5. Fluorescent ligand binding assay of dye-labeled ACBP
To assure that covalent labeling of his-ACBP with ﬂuorescent tags
(TR, Cy5) did not alter his-ACBP function, the afﬁnity of dye-labeled
ACBP for a long chain fatty acyl CoA ligand was determined. Cis-
parinaroyl-CoA is the CoA thioester of a naturally-occurring ﬂuor-
escent fatty acid, i.e. cis-parinaric acid [23,24,28]. Cis-parinaroyl-CoA
binding was determined by measuring: i) the increase in ligand
ﬂuorescence intensity at 420 nm with excitation at 320 nm, upon
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ﬂuorescence intensity at 340 nm upon excitation at 280 nm upon
ligand binding to protein. Tyr and Trp ﬂuorescence emission overlaps
with cis-parinaroyl-CoA emission — thereby making this an effective
donor/acceptor pair for ﬂuorescence resonance energy transfer when
the two are in close proximity, i.e. a few angstroms. Usually, 30 nM
dye-labeled ACBP was titrated with 2.5–300 nM cis-parinaroyl CoA
and ﬂuorescence emission spectra were recorded: i) from 380–
440 nm upon excitation of ligand at 320 nm; ii) from 290–400 nm
upon excitation at 280 nm. Fluorescence emission spectra were
obtained using a PC1 photon counting ﬂuorimeter (ISS Inc. Urbana, IL).
Maximum ﬂuorescence intensities of cis-parinaroyl-CoA at 420 nm at
each titration point were plotted versus ligand concentrations after
subtraction of corresponding control values in which ACBP was not
present. In quenching experiments, F0–F, the amount of quenching at
each titration point was plotted against the corresponding ligand
concentration. Bmax and Kd values were obtained by curve ﬁtting,
using SigmaPlot software (SYSTAT, San Jose, CA), and ﬁtting to the one
site binding saturation option of the program as described earlier for
untagged fatty acyl CoA binding proteins.
2.6. Fluorescent sterol synthesis and incorporation into large unilamellar
vesicles (LUV): dansyl-cholestanol (DChol) and dehydroergosterol (DHE)
Dansyl-cholesterol was synthesized as previously described [29].
Dehydroergosterol was prepared according to a modiﬁed protocol of
an earlier procedure as described earlier [30–32]. DChol and DHEwere
incorporated into model membrane vesicles (i.e. LUV, large uni-
lamellar vesicles) for incorporation into cells basically as described
earlier for DHE [32]. LUVs consisting of 35% DChol or DHE and 65% 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) molar
fractions were prepared as described [32]. Brieﬂy, DChol/DHE and
POPC dissolved in 95% ethanol were mixed and dried under nitrogen
ﬂow to produce a thin ﬁlm which was dehydrated under vacuum
overnight and dissolved in phosphate buffer saline (PBS) at 37 °C. The
aqueous solution of DChol/DHE and POPC was then subjected to
5 cycles of freezing at −70 °C and thawing at 37 °C, and vigorous
vortexing at each cycle. The resultant multilamellar dispersion was
ﬁltered through a 0.2 μm membrane (Millipore, Bedford, MA) and
extruded by the use of an Avanti Mini-Extruder with a 0.1 μm
polycarbonatemembrane (Whatman). This stock solution of LUVswas
diluted to 20 μg DChol or DHE/ml of cell culture medium.
2.7. Cell culture
For incorporation of ﬂuorescent-tagged ACBP as well as ﬂuorescent
sterols for real time imaging by laser scanning confocal microscopy,
COS-7 cells were seeded in 2-well LabTek chamber glasses and
cultured in Dulbecomodiﬁed Eagle's medium (DMEM) containing 10%
fetal bovine serum (FBS) under 5% CO2, at 37 °C, until 90% conﬂuence
as described [22].
2.8. Incorporation of DChol and DHE into cultured cells
Two different vehicles were used to deliver ﬂuorescent sterols to
COS-7 cells, namely fetal bovine serum (10% in DMEM) and LUV
described above — both providing 20 μg sterol per ml of culture
medium. When serumwas utilized as DChol vehicle, COS-7 cells were
seeded in LabTek chamber glasses and grown in 10% fetal bovine
serum (FBS)-containing DMEM. At 80% conﬂuence, the cells were
washed with phosphate buffer saline (PBS) three times, shortly and
incubated with serum-free DMEM culture medium for 30 min at 5%
CO2, 37 °C. Afterwards, the serum-free DMEM was replaced with 10%
FBS/DMEM inwhich DChol and either an organelle ﬂuorescent marker
or ﬂuorescent-labeled ACBP were added at the same time with DChol.
The latter (DChol) was added from a 20 mg/ml ethanol stock solutionto a ﬁnal concentration of 20 μg/ml in the FBS/DMEM culture medium.
Alternately DHE was added in the form of LUVs prepared as described
above. COS-7 cells were ﬁrst cultured in 10% FBS/DMEMmedium, for 1
day at 5% CO2 and 37 °C; the cells were then supplemented with
DChol/DHE-POPC LUV solution at a ﬁnal concentration of 20 μg/ml
sterol in FBS/DMEM; cells were grown for two more days under the
same conditions. Before confocal microscopy imaging, cells were
processed for the uptake of ﬂuorescent ACBP in the absence or
presence of Pep-1 (as described below).
2.9. Pep-1-mediated uptake of ﬂuorescent labeled ACBP into COS-7 cells
COS-7 cells were grown in 2-well LabTek chamber glasses in 10%
FBS-containing DMEM to 80% conﬂuence. Texas Red- or Cy5-labeled
ACBP (0.5 μg/ml) was ﬁrst mixed with Pep-1 (0.5 μg/ml) for 30 min at
room temperature in order to form protein-peptide complex, then
added to cells in serum-depleted DMEM. After incubation for 30 min
at 37 °C, the ACBP/Pep-1 complex was washed from cells with
phosphate buffer saline and replaced with 10% FBS-DMEM. In time-
course experiments, laser scanning confocal microscopy (LSCM) was
performed after the addition of serum-DMEM at various time points
from 5 min to several hours as indicated in Results section. In
experiments where imaging was done at time points equal or longer
than 30 min, the staining of cell nuclei with vital Hoechst DNA dye (at
a ﬁnal concentration of 1 μg/ml) was applied; the nuclear marker was
added at 30 min before taking the confocal microscopy images.
2.10. Distribution of DChol and DHE with endocytic markers in plasma
membranes of living cells
Uptake of DChol and DHE into endocytic regions of plasma
membranes was determined by laser scanning confocal microscopy
(LSCM) imaging and multiphoton laser scanning microscopy
(MPLSM), respectively. DChol and DHE at the plasma membrane
were colocalized with known lipid raft and endocytosis markers
such as: i) cholera toxin subunit B, marker for GM1 in lipid rafts; ii)
transferrin, marker for clathrin dependent endocytosis; iii) 10 kDa
dextran, marker of macropinocytosis. Brieﬂy, cells were cultured in
DMEM supplemented with 10% serum (FBS) for 2 days, until they
reached 80% conﬂuence. Just before confocal microscopy imaging,
cells were washed and incubated with cold PBS on ice (at 4 °C) for
20 min. Simultaneously, a cold solution of DMEM supplemented
with 10% FBS, 20 μM DChol and the raft or endocytosis ﬂuorescent
marker, was prepared and cooled on ice. The concentrations of
markers were: i) 5 μg/ml for cholera toxin labeled with Alexa Fluor
488 (CT-488) or Alexa Fluor 594 (CT-594); ii) 100 μg/ml Texas Red-
transferrin; iii) 100 μg/ml Texas Red-dextran (10 kDa). Cells were
incubated with this mix of FBS, DMEM, DChol, and endocytic marker
for 5 more minutes on ice, and quickly processed for LSCM of DChol
and markers (see below) or multiphoton laser scanning microscopy
(MPLSM) for DHE and markers (see below) to minimize the
redistribution and internalization of labels as reported previously
by our laboratory [32].
2.11. Distribution of ﬂuorescent sterols and dye-labeled ACBP with
endocytic and organelle markers
In order to assess colocalization of ﬂuorescent-tagged ACBP with
ﬂuorescent sterols (DChol, DHE) and vital dye labeled membranes/
organelles, the ﬂuorescent sterols and ﬂuorescent-tagged ACBP were
incorporated into COS-7 cells as described above, imaged by LSCM
(DChol) or MPLSM (DHE), and colocalized in living cells as described
earlier [32]. Vital dyes used were cholera toxin B-Alexa Fluor 488 (CT-
488) conjugate (marker for plasma membrane lipid rafts), Texas Red-
dextran (marker for macropinocytic vesicles), Texas Red-transferrin
(marker for clathrin coated pits and vesicles), LysoTracker Yellow-
Fig. 1. Mass spectrometry analysis of Texas Red-labeled ACBP. Distinctive peaks of MS
detection intensity can be seen, corresponding to: unlabeled ACBP (MW 10946); TR
dye-ACBP, molar ratio 1:1 (MW11649); TR-ACBP, molar ratio 2:1 (MW12352); TR-ACBP,
molar ratio 3:1 (MW 13055), and 4:1 (MW 13759).
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BODIPY-FL, marker for endoplasmic reticulum); NBD-C6-ceramide
(marker for Golgi); MitoFluor Green (marker for mitochondria); and
Hoechst 33342 (marker for nucleus). All markers were used as
recommended by manufacturer. Dye-labeled ACBP (TR or Cy5)
colocalization with ﬂuorescent sterols or vital dye ﬂuorescent
organelle markers was also performed after incorporating dye-labeled
ACBP in the presence of Pep-1. Brieﬂy, 2 h after incubation with
serum-supplemented DMEM at 37 °C post TR-ACBP±Pep-1 treatment,
cells were ﬁrst labeled with 1 μg/ml Hoechst 33342 nuclear dye in
serum/DMEM at 37 °C for 30 min, and then with LysoTracker Yellow
(1 μM in serum/DMEM at 37 °C for 30 min), ER-Tracker Green (1 μM in
Hank's solution with Ca2+ and Mg2+, for 15 min at 37 °C) or MitoFluor
Green (100 nM in serum/DMEM at 37 °C for 30 min). Labeling of Golgi
complex with NBD-C6-ceramide/albumin was also performed after
pre-treatment of cells with TR-ACBP±Pep-1 and nuclear marker, by
incubating cells with 5 μM NBD-C6-ceramide/albumin in Hank's
solution for 30 min at 37 °C as recommended by manufacturer.
2.12. Real-time imaging of ﬂuorescent sterols, dye-labeled ACBP, and
markers in living cells
For all studies involving imaging of DChol, LSCMwas performed by
using a ﬂuorescence confocal imaging system (MRC-1024, Bio-Rad,
Hercules, CA) consisting of an inverted microscope (Axiovert 135,
Zeiss, New York, NY) equipped with three independent low-noise
photomultiplier tube (PMT) channels. The excitation light (488 nm,
568 nm and 647 nm) from a 15mWkrypton-argon laser was delivered
to sample through a 63X oil immersion objective (Zeiss Plan-Fluor,
New York NY), with numerical aperture of 1.4, while the emission
ﬂuorescence light was detected in photomultiplier tubes (PMTs) by
using emission ﬁlters 585 LP in PMT1, 540/30 in PMT2, and 680/32 in
PMT3. Since DHE is a UV excitable ﬂuorescent sterol (excited in the
range 300–324 nm), but is readily bleached by direct UV excitation,
DHE was instead excited by three-photon excitation at 900 nm
(conditions under which DHE is muchmore stable, i.e. undergoes very
little photobleaching) and DHE ﬂuorescence emission was imaged by
MPLSM using the MRC-1024 multiphoton conﬁguration and external
detectors as described earlier [32,33]. Images were acquired and
analyzed with LaserSharp (Bio-Rad) and MetaMorph (Advanced
Scientiﬁc Imaging) [22,32,33].
2.13. Immunoﬂuorescence LSCM of ACBP localization in ﬁxed cells
T-7 rat hepatoma cells (received from Dr. Charles Baum,
University of Chicago, Chicago, IL) expressing high amounts of
endogenous ACBP [22] were grown in 2-well LabTek chamber slides
in high-glucose DMEM with 10% FBS, and ﬁxed with 4% glutaralde-
hyde at 37 °C for 30 min, residual aldehyde was quenched with
ammonium chloride, and then nonspeciﬁc antibody binding was
blocked with 5% FBS in Hank's solution. Primary antibodies raised
against ACBP were produced locally in rabbit or rat [22,24,34], while
all other primary and secondary antibodies used as membrane/
organelle markers were commercially purchased as stated under
Materials. Double immunolabeling LSCM to colocalize ACBP with
membrane organelle markers was performed similarly as described
earlier for ACBP and speciﬁc organelle markers including anti-
cathepsin D antibody (lysosomes), anti-mitochondrial HSP70 anti-
body (mitochondria), concanavalin-FITC (marker for endoplasmic
reticulum) and wheat germ agglutinin-FITC (marker for Golgi
system) [22]. Secondary antibodies were Texas Red- or FITC-labeled
antirabbit, antirat, anti-mouse IgGs. Cells that had been ﬁxed and
blocked for nonspeciﬁc binding were incubated with 5 μg/ml primary
antibody in 2% FBS/Hank's solution for 1 h at room temperature
followed by three washings with Hank's solution and 1 h incubation
with 5 μg/ml secondary antibody at room temperature. After washingaway the secondary antibody with Hank's solution, cells were
prepared for confocal microscopy by the use of anti-fading kit
SlowFade from Molecular Probes (Invitrogen, Eugene, OR).
3. Results
3.1. Structural and functional characterization of Texas Red-labeled ACBP
(TR-ACBP)
TR-ACBP was analyzed by mass spectrometry to determine the
number of covalently attached TR molecules per molecule of protein.
The small intensity peak detected at 10946.01 Da (17% of total
intensity) corresponded to unlabeled his-ACBP (Fig. 1). Additional
mass spectral peaks at 11648.94, 12352.04, and 13055.20 Da corre-
sponded to his-ACBP labeled with one (43% of total intensity), two
(26% of total intensity), or three (20% of total intensity) TR/his-ACBP,
respectively. Thus, the TR labeled nearly 90% of ACBP and TR-ACBP
with a 1:1 dye-to-protein molar ratio as the highest fraction.
To examine if TR labeling altered ACBP structure, samples were
examined by SDS-PAGE (detect cross-linking), Western blotting
(detect altered antibody speciﬁcity), and circular dichroism (CD,
detect altered secondary structure). TR labeling did not result in the
formation of intermolecular cross-links between his-ACBP protein
molecules as shown by SDS-PAGE which detected a single band (Fig.
2A), consistent with the molecular weight of monomeric protein
determined by mass spectrometry (Fig. 1). Western blotting demon-
strated that ACBP antigenic speciﬁcity was maintained after labeling
with TR (Fig. 2B). CD spectra of TR-ACBP and ACBP were similar,
indicating that TR labeling did not alter ACBP molar ellipticity or
secondary structure (Fig. 2C).
To determine if TR labeling altered his-ACBP ligand interaction,
binding of cis-parinaroyl-CoA was examined (Fig. 2D). Quantitative
analysis of multiple saturation binding curves yielded a Kd value of
40.8+9.8 nM for TR-ACBP (Fig. 2D). Saturation binding was conﬁrmed
by quenching in ACBP Tyr/Trp ﬂuorescence upon cis-parinaroyl-CoA
binding which yielded a Kd of 21.3+5.2 nM for TR-ACBP (Fig. 2E).
Previous analysis of cis-parinaroyl-CoA binding by unlabeled ACBP
using the same binding assays demonstrated Kd's near 5 nM, [24].
Although TR labeling decreased his-ACBP's ligand binding afﬁnity
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CoA was still high, i.e. low nM range. Since the intracellular, cytosolic
long chain acyl-CoA concentration in COS-7 cells in culture is in the μM
range, this suggested that TR-ACBP maintained its function as an
effective fatty acyl CoA binding protein in the physiological range of
fatty acyl CoA concentrations in the cytosol [35,36].
Taken together the above data showed that Texas Red labeling did
not induce formation of protein-protein dimers, alter antigenic
responsiveness, or alter ACBP secondary structure and minimally
altered ACBP function in ligand binding.
3.2. Incorporation of dansyl-cholesterol (DChol) from serum into the
plasma membrane of live COS-7 cells
In order to resolve whether basal or Pep-1 mediated translocation
of exogenous proteins such as TR-ACBP results in exit of endocytosed
TR-ACBP into the cytoplasm/nucleoplasm, it was important to develop
probe molecules that reported on plasma membranes, endocytic
membranes, membrane domains, and membranous organelles. Since
all cellular membranes (except the inner mitochondrial membrane) as
well as plasma membrane cholesterol-rich and –poor microdomains
contain cholesterol, the possibility that ﬂuorescent sterols dansyl-
cholesterol (DChol) and dehydroergosterol (DHE) could be used as
markers reporting on these membranes, domains, and membrane
organelles was determined. To examine DChol incorporation intoFig. 2. Structural and functional characterization of Texas Red-labeled ACBP (TR-ACBP). (A)
markers. (B) Western blot of TR-ACBP (lane 2) and unlabeled ACBP (lane 3); lane 1 shows mo
unlabeled ACBP (open circles). (D) Ligand (cis-parinaroyl-CoA) binding curve of TR-ACBP as
320 nm, upon binding to protein. (F) Binding curve as determined by measuring quenching
titration with cis-parinaroyl-CoA.plasma membrane cholesterol-rich microdomains in the absence
signiﬁcant endocytic uptake, COS-7 cells were incubated with DChol
in the presence of serum and DChol at 4 °C (temperature at which
energy-dependent endocytic mechanisms are inhibited). Immediately
thereafter, the co-distribution of serum-delivered DChol with cholera
toxin subunit B labeled with Alexa Fluor 488 or 594 (CT-488 or CT-
594) was then determined by simultaneously acquiring LSCM images
of DChol (green) and Alexa Fluor CT dyes (red) through separate
photomultipliers. Superposition of Dchol (green) and cholera toxin
(red) images when cholera toxinwas labeled with CT488 (Fig. 3A) and
594 (Fig. 3C) dyes, respectively, revealed that incubation at 4 °C
resulted in most of the DChol and Alexa Fluor-labeled cholera toxin B
appearing at the plasma membrane as highly colocalized (yellow/
orange pixels). Some DChol (green) was diffusely distributed in the
cytoplasm, and only very little of the Alexa Fluor CT probes, especially
CT488, appeared inside the cells. To conﬁrm this pattern of
distribution, display of only the colocalized pixels (yellow) of DChol
with CT-488 (Fig. 3B) and CT-594 (Fig. 3D), respectively, indicated high
colocalization at the plasma membrane, but only rarely detected
within the cell. The colocalization pattern at the plasma membrane
reﬂected mostly high intensity clusters of colocalized DChol/Alexa
Fluor CT pixels interspersed with small less intense areas of relatively
low colocalization (Fig. 3B and D), low DChol (Fig. 3A and C, green
pixels), and/or low Alexa Fluor CT (Fig. 3A and C, red pixels).
Quantitative analysis of DChol colocalization in multiple cells labeledSDS-PAGE of TR-ACBP (lane 2), unlabeled ACBP (lane 3); lane 1 shows molecular size
lecular size marker. (C) Circular dichroic (CD) spectrum of TR-ACBP (solid circles) versus
determined by increase in ligand ﬂuorescence intensity at 420 nm with excitation at
of TR-ACBP intrinsic (Tyr/Trp) ﬂuorescence at 340 nm with excitation at 280 nm, upon
Fig. 3. Colocalization of dansyl-cholesterol (DChol) with lipid raft and endocytosis markers in live COS-7 cells. (A, C) Overlay images of Dchol (green) and cholera toxin B (CT) labeled
with Alexa Fluor(AF)-488 (A) or AF-594 (C). (B, D) Colocalized pixels from A and C, respectively were selected (shown in yellow). (E) Bar graph of Dchol colocalization with CT488 or
CT594 within ﬁrst 5 min at room temperature after coincubation of DChol and cholera toxin with COS-7 cells at 4 °C for 20 min. (F-H) Colocalization of Dchol with TR-transferrin: (F)
Overlay of DChol (green) and TR-transferrin (red) ﬂuorescence images; (G) Colocalized pixels from F were selected (shown in yellow); (H) Bar graph of DChol colocalization with TR-
transferrin after 1 h incubationwith cells at 37 °C. (I–M) Colocalization analysis for DChol with TR-dextran: (I, K) Overlay of Dchol (green) and TR-dextran (red) ﬂuorescence images at
10 min, RT and 1 h, 37 °C incubation of cells with ﬂuorescent markers, respectively; J, L, Colocalized pixels from I, K were selected (shown in yellow); (M) Bar graph of DChol
colocalization with TR-dextran at 10 min, RT and 1 h, 37 °C.
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DChol was found to be colocalized with CT-488 (Fig. 3E) and CT-594
(Fig. 3E), respectively. Thus, at low temperature (inhibits energy-
driven endocytosis by vesicular mechanisms) most DChol was
colocalized with cholera toxin-labeled cholesterol-rich microdomainsat the plasma membrane, while 25–42% of DChol was not colocalized
with Alexa Fluor-CT but resided in other regions of the plasma
membrane or with some localized within the cells.
These data suggested that: i) DChol uptake via GM1 containing
cholesterol-rich microdomains mediated endocytosis into COS-7 cells
431A.D. Petrescu et al. / Biochimica et Biophysica Acta 1788 (2009) 425–441was largely inhibited at 4 °C; ii) about 58–75% of DChol was associated
with GM1-containing plasma membrane cholesterol-rich microdo-
mains at 4 °C. Thus, serum-delivered DChol incubated at 4 °C with
COS-7 cells appeared most highly colocalized with the GM1-marker
cholera toxin subunit B at the plasma membrane cholesterol-rich
microdomains.
3.3. Uptake of serum-delivered dansyl-cholesterol (DChol) by endocytic
pathways in live COS-7 cells: clathrin-mediated pathway and
macropinocytosis
To further investigate if DChol also enters the COS7 clathrin coated
vesicle-mediated endocytosis pathway (via LDL receptors located
within plasma membrane clathrin- domains), cells were coincubated
with DChol and Texas-Red-labeled transferrin (TR-transferrin, a
marker for clathrin- mediated endocytosis) in the presence of serum
as DChol vehicle, at 4 °C or at permissive temperature, i.e. 37 °C.
Coincubation of cells with DChol and TR-transferrin at 4 °C resulted in
most of the TR-transferrin outside the cells with no detectable uptake
of it into the cells (data not shown). Subsequent additional incubation
for up to 1 h at 37 °C resulted in DChol and TR-transferrin detectable
inside the cells where DChol was distributed diffusely in the cytosol
and in punctuate vesicles that did not overlap with TR-transferrin
vesicles (not shown). However, after 1 hour incubation of cells at 37 °CFig. 4. Colocalization of Texas Red-labeled ACBP with endocytosis markers in live COS-7 cells.
incubated with cells at 4 °C for 20 min as described under Materials and methods. (A1, A2) Im
after incubation at 4 °C. (A3) Overlay of TR-ACBP (red) and Alexa488-dextran (green) images.
B4) same as in A1-A4 but when images were taken after 60 min incubation of COS-7 cells wi
TR-ACBP, respectively, in COS-7 cells after 10 min at RT post 4 °C incubation. (C3) Overlay of
pixels in C3 were selected and are shown in yellow. (D1–D4) same as in C1–C4 but after 60the TR-transferrin signiﬁcantly colocalized with DChol inside the cells
as shown by overlay of the simultaneously acquired DChol (green) and
TR-transferrin (red) images (Fig. 3F). Display of only colocalized pixels
(yellow) demonstrated that DChol which colocalized with TR-
transferrin was distributed mostly inside cells in vesicular structures,
but also in vesicles near the plasma membrane (Fig. 3G). Quantitative
estimation of DChol/TR-transferrin colocalization in multiple cells
indicated that 33% of DChol taken up into the cells was codistributed
with TR-transferrin inside cells within vesicular structures after 1 h
incubation of cells at 37 °C. Conversely, 42% of TR-transferrin was
colocalized with DChol inside the cells—suggesting that incubation
with DChol /serum had saturated the clathrin mediated pathway.
To determine if DChol also entered the macropinocytosis pathway
of COS7 cells, cells were coincubated with DChol - in the presence of
serum- and Texas Red-dextran (marker of ﬂuid-phase endocytosis or
macropinocytosis) at 4 °C for 20 min followed by additional
coincubation at 24 °C for 10 min or 37 °C for 1 h. When cells were
imaged after DChol /serum/ TR-dextran incubation at 24 °C for 10 min,
overlay of simultaneously acquired images of DChol (green) and TR-
dextran (red) showed a large number of yellow/orange punctuate
structures indicating DChol/TR-dextran colocalization as well as
additional DChol (green) in separate vesicular structures (Fig. 3I).
Display of only the selected colocalized pixels (yellow) showed a
bright punctuate distribution of colocalized pixels throughout the cell,Amix of TR-ACBP and either Alexa Fluor 488-dextran or Alexa Fluor 488-transferrinwas
ages of Alexa488-dextran and TR-ACBP, respectively, in cells at a short time (5–10 min)
(A4) Colocalized red and green pixels in A3 were selected and are shown in yellow. (B1–
th TR-ACBP and Alexa488-dextran at 37 °C. (C1, C2) Images of Alexa488-transferrin and
TR-ACBP (red) and Alexa488-transferrin (green) images. (C4) Colocalized red and green
min incubation of cells with TR-ACBP and Alexa488-transferrin at 37 °C.
Fig. 5. DChol/TR-ACBP confocal colocalization monitored for TR-ACBP uptake into live COS-7 cells labeled with DChol/serum. (A) Colocalized pixels from TR-ACBP/Dchol overlay
images (collected by LSCMwith excitation of Texas Red and dansyl at 568 nm and 408 nm respectively, and emission ﬁlters HQ598/40 and 540/30 respectively); images were taken at
time points as indicated from 30 min up to 2 h of chase after pulse, before and after serum addition. (B) Bar plot of percent TR-ACBP colocalized with DChol in the absence (blue) or
presence (black) of Pep1, versus time. (C) Bar plot of percent TR-ACBP which was not associated with DChol versus time, in the absence (blue) or presence (black) of Pep1.
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pattern was much more extensive and intense than that observed
with TR-transferrin colocalization, even at longer time (Fig. 3J vs 3G).
Quantitative analysis showed that 78% of DChol was colocalized with
TR-dextran under these conditions (Fig. 3M). DChol was colocalized
with TR-dextran nearly 3-fold more than TR-dextran colocalized with
DChol — suggesting that incubation with serum-delivered DChol did
not saturate the macropinocytosis pathway. In addition, the 78%
colocalization of DChol with TR-dextran taken up bymacropinocytosis
was two fold higher than through the clathrin-mediated endocytosis
(36% colocalization). It should be noted, however, that when cells were
incubated with DChol/serum/ TR-dextran at 37 °C for 1 h, the overlay
of simultaneously acquired images of DChol (green) and TR-dextran
(red) showed much of the TR-dextran had recycled to the cell surface
andwas excreted back into themedium (red) (Fig. 3K). However, some
TR-dextran remained within the cells colocalized with DChol in large
perinuclear yellow/orange structures (Fig. 3K). Display of only the
selected colocalized pixels (yellow) exhibited a bright punctuate
codistribution only in the larger perinuclear areas (Fig. 3L). Quanti-
tative analysis demonstrated that only 40% of DChol was colocalized
with TR-dextran under these conditions (Fig. 3M). This suggestedrecycling and excretion of most of TR-dextran to leave fewer
punctuate DChol/TR-dextran containing vesicles, consistent with the
known pattern of ﬂuid-phase macropinocytic uptake of large particles
such as TR-dextran.
In summary, i) at 4 °C very little serum DChol delivered to plasma
membranes was internalized, ii) at short time of incubation at 24 °C,
DChol appeared highly colocalized with the macropinocytosis probe
TR-dextran inside cells; iii) after 1 h incubation at 37 °C, DChol was
equally distributed with TR-transferrin and TR-dextran. Thus, DChol
was taken up from serum into cells by endocytic pathways involving
not only plasma membrane cholesterol-rich microdomains (GM1,
macropinocytosis) but also cholesterol-poor microdomain (clathrin-
mediated endocytosis) pathways.
3.4. Uptake of Texas Red-Acyl CoA Binding Protein (TR-ACBP) by live
COS-7 cells
To determine if TR-ACBP is internalized by clathrin-dependent
endocytosis or macropinocytosis, COS-7 cells were cooled at 4 °C and
treated with ice-cold medium containing serum, TR-ACBP and either
Alexa Fluor 488-transferrin (marker for clathrinmediated endocytosis
433A.D. Petrescu et al. / Biochimica et Biophysica Acta 1788 (2009) 425–441pathway) or Alexa Fluor 488-dextran (marker for macropinocytosis
pathway) followed by incubation at 37 °C for 10, 30, 60, or 120 min,
and LSCM.
After short incubation times (e.g. 10–30 min), the Alexa488-
dextran (macropinocytosis marker) (Fig. 4A1) was distributed not only
at the cell surface but also taken up inside the cells as very small
punctuate vesicles throughout the cell interior except for nuclei which
appeared dark. Likewise, after short incubation times (e.g. 10–30 min)
the TR-ACBP (Fig. 4A2) was taken up and distributed within cells as
very small punctuate vesicles as well as throughout the cell interior
and little in nuclei. At longer incubation time (2 h) more of the
Alexa488-dextran (Fig. 4B1) and TR-ACBP (Fig. 4B2) were taken up
into the cell interior and TR-ACBP appeared increasingly as higher
intensity, larger punctuate vesicular structures became more promi-Fig. 6. Colocalization of TR-ACBP and DChol in membrane-bound vesicles/organelles versus c
serum±Pep-1 at 37 °C (see Materials and methods) and simultaneous images of the two ﬂu
delivery starting point. (A1) DChol image at 10 min of serum (no Pep-1) incubation. (A2) TR-A
serum (no Pep-1) incubation. (D) Fluorograph of red/green pixel colocalization when the en
colocalization of a small area which was selected within cytosol (diffuse pattern of ﬂuoresce
which was selected within vesicle/plasma membranes. (G–I) as in (A–C) respectively except t
plus Pep-1. (J– L) as in (D–F) respectively, except that images were taken of cells which wernent within the cell cytoplasm and near nuclei. Superposition of the
images (Fig. 4A3), and even more so display of only colocalized pixels
(Fig. 4A4), showed at short incubation time (10–30 min) the TR-ACBP
was extensively colocalized with the macropinocytosis marker in very
small punctuate vesicular structures distributed throughout the
cytoplasm. At longer incubation times (1–2 h), superposition (Fig.
4B3) and display of only colocalized pixels (Fig. 4B4) showed even
more intensity of colocalized TR-ACBP with Alexa488 dextran in the
cell interior as well as some very bright punctuate regions near the
nuclei.
With regards to the clathrin mediated endocytic pathway, after
short incubation times (e.g. 10–30 min), the Alexa488-transferrin
(clathrin mediated endocytosis marker) (Fig. 4C1) was distributed as
many bright, larger punctuate vesicles, especially near the plasmaytosol of COS-7 cells. TR-ACBP and DChol were coincubated with cells in the presence of
orescent markers were acquired at short (10 min) or long (90 min) time periods after
CBP in same cells as in A1. (A3) Overlay of DChol (green) and TR-ACBP (red) at 10 min of
tire area shown in panel A was selected for analysis. (E) Fluorograph of red/green pixel
nt markers inside cells). (F) Fluorograph of red/green pixel colocalization of a small area
hat images were taken of cells which were incubated with DChol and TR-ACBP in serum
e incubated with DChol and TR-ACBP in serum plus Pep-1.
Fig. 7. DHE/TR-ACBP confocal colocalization monitored for TR-ACBP uptake into live COS-7 cells labeled with DHE/LUVs. (A–C) DHE ﬂuorescence images in cells at different time
points after addition of TR-ACBP. (D–F) TR-ACBP ﬂuorescence images in same cells as shown in panels A-C. (G–I) TR-ACBP/DHE overlay images; TR-ACBP is shown in green, and DHE in
red. (J–L) Fluorographs corresponding to each colocalization image shown above, respectively. (M) Bar plot of TR-ACBP percentage which was colocalized with DHE in the absence
and presence of Pep-1, versus time.
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intense, but more diffusely distributed small punctuate regions
throughout the cell interior. In both cases neither marker appeared
within the nuclei. At longer incubation time (1–2 h) the Alexa488-
transferrin was distributed primarily in bright punctuate regions in
the perinuclear area (Fig. 4D1) while TR-ACBP appeared not only as
punctuate regions within the cell interior, but also in the nuclei (Fig.
4D2). Superposition of the images (Fig. 4C3), and evenmore so display
of only colocalized pixels (Fig. 4C4), showed at short incubation time
(10–30 min) the TR-ACBP was somewhat colocalized with the clathrin
endocytosis pathway marker primarily in the perinuclear area and
more diffusely in the cytoplasm. At longer incubation times (1–2 h),
superposition (Fig. 4D3) and display of only colocalized pixels (Fig.
4D4) showed high intensity of colocalized TR-ACBP with Alexa488
dextran primarily in the perinuclear region and in larger punctuate
structures within the cytoplasm. However, both at short and long
incubation times, the intensity of TR-ACBP colocalization with the
clathrin pathway marker (Fig. 4C4 and D4) was much less than that
observed with the macropinocytosis marker (Fig. 4A4 and B4). Taken
together these data suggest that TR-ACBP was internalized by both
endocytic pathways, with the extent of macropinocytic uptake being
more prevalent than that mediated by the clathrin endocytic pathway.
Interestingly, TR-ACBPwas taken up into COS7 cells in the absence of a
cell penetrating peptide like Pep-1, albeit 2.4-fold less efﬁciently (see
below). Uptake in the absence of Pep-1 was not due to TR labeling orthe presence of the his tag in TR-his-ACBP. Control experiments
showed that native ACBP (with no His or any other tag) also entered
cells even in the absence of Pep-1.
3.5. Colocalization of Texas Red-ACBP with DChol in COS-7 cells
preincubated with DChol in serum containing medium: effect of Pep-1
While the above studies indicate that cells can take up TR-ACBP
by endocytic pathways, they do not provide insight as to the relative
quantity of TR-ACBP that may enter the cytoplasm vs that retained in
membranous structures, or if either process is facilitated by CPPs
such as Pep-1. Therefore, the effect of Pep-1 on TR-ACBP uptake into
COS-7 cells and colocalization with serum-delivered DChol was
studied by incubating COS-7 cells with TR-ACBP (or TR-ACBP
complexed with Pep-1) and DChol in serum-free (or serum-contain-
ing DMEM medium), followed by LSCM. In the absence of serum, no
DChol was colocalized with TR-ACBP (yellow) inside the cells,
regardless of the absence or presence of Pep-1 (Fig. 5A and B).
Although a few yellow colocalized pixels were detected at the cell
surface plasma membranes, quantitative analysis of multiple pixel
ﬂuorograms showed very little colocalization (3%) when cells were
incubated with serum-free medium (Fig. 5B, left bar). In contrast,
serum in the medium signiﬁcantly facilitated DChol uptake: 12±1.8 a.
u/cell at 30 min, 19±2.2 a.u./cell at 60 min, and 33±4.3 a.u./cell at 2 h
after addition of serum to cells in the presence of DChol in DMEM
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containing medium (30 min, 120 min) resulted in increased
appearance of colocalized TR-ACBP/DChol pixels inside cells, in a
bright punctuate pattern, especially in the perinuclear area (Fig. 5A,
top row). In the presence of serum, TR-ACBP was increasingly
colocalized with DChol to a maximum near 40% (Fig. 5B). Con-
comitantly, the quantity of TR-ACBP not colocalized with DChol in
vesicles/membranous structures was about 50–60% (Fig. 5C).
Pep-1 facilitated the uptake of TR-ACBP by COS-7 cells. Quantitative
analysis of colocalization images (Fig. 5A, bottom row vs top row)
indicated that Pep-1 increased TR-ACBP uptake such that 2.4 foldmore
TR-ACBP per cell was detected in the presence of Pep1/serum as
compared to serum alone. Pep-1 increased the extent of colocalized
TR-ACBP/DChol (yellow) pixels in both the cell interior and at the
plasma membrane, especially in cells incubated with DChol in serum-
containing medium (Fig. 5A, bottom row vs top row). TR-ACBP/DChol
colocalization was increased in the absence of serum (6% vs 3% ) and
even more in the presence of serum—reaching a maximum of nearly
75% vs 35% (Fig. 5B). However, nearly 25% of TR-ACBP was not
colocalized with DChol even at the longest incubation time examined
(Fig. 5C).
To further determine where inside cells (cultured with DChol in
serum containing medium) the TR-ACBP was colocalized with DChol,
very small areas displaying the presence of DChol (Fig. 6A) and either
high intensity, punctuate distributed TR-ACBP (vesicles/membranes,
Fig. 6B) or diffuse non-punctate TR-ACBP intensity (cytosol, Fig. 6B)
were selected for colocalization analysis. Superposition of DChol (Fig.
6A) and TR-ACBP (Fig. 6B) yielded a combined image (Fig. 6C) showing
signiﬁcant yellow/orange colocalized pixels with highest intensities in
punctuate structures at the perinuclear regions of the cells and low
intensities diffuse in the cytoplasm. Fluorographs of different areasFig. 8. Colocalization of Cy5-ACBP with plasma membrane lipid rafts and lysosomes in live ce
of Pep-1 at 37 °C for 30 min, then labeled with Hoechst nuclear marker, and for either plasma
for lysosomes with LysoTracker dye (at 37 °C for 30 min), as described in Materials and metho
nuclear Hoechst dye (green) images. (B) Only colocalized red and blue pixels in panel Awere s
cholera toxin in COS-7 cells. (D) Overlay of Cy5-ACBP (blue), lysosome marker (Lysotracker, re
markers were selected and shown in magenta. (F) Bar graph of percent colocalization of Cyselected from the latter image are shown (Fig. 6D–F) as follows: The
ﬂuorograph in Fig. 6D illustrates the distribution and colocalization
coefﬁcientswhen the entire area of the overlay imagewas selected. Fig.
6E and F exhibit the distribution and colocalization coefﬁcients for
small areas which were selected within cytosol (diffuse) or vesicles
(compact), respectively. The latter graphs suggested that in the more
diffuse areas (cytosol) only 13% of TR-ACBP was co-distributed with
DChol, while the more punctuate and intense areas (vesicles,
membranes) as much as 97% of TR-ACBP was colocalized with DChol.
Incubation of cells with Pep-1/TR-ACBP complex in serum-containing
mediumhad no effect on the degree of colocalizationwithDChol in the
corresponding respective regions within the cell (Fig. 6G–L).
Taken together, these results indicate that: (i) serum facilitated TR-
ACBP uptake regardless of the presence of Pep-1; (ii) in the presence of
serum Pep-1 modestly increased TR-ACBP uptake 2.4-fold; (iii) Pep-1
increased the proportion of TR-colocalized with DChol in membra-
nous structures at intermediate (30–90 min) incubation times—
consistent with increased endocytic uptake; and (iv) Pep-1 did not
signiﬁcantly alter the proportion of TR-ACBP free in the cytoplasm (i.e.
not colocalized with DChol-containing membranous structures) at
longer incubation times.
3.6. Colocalization of TR-ACBP with dehyroergosterol (DHE) incorporated
into COS-7 cells in the form of DHE/POPC LUVs
Because DChol is a synthetic, ﬂuorescent sterol with a dansyl side
group not occurring in nature, the possibility that the high degree of
TR-ACBP codistribution with DChol on uptake into COS-7 cells might
be speciﬁc to this ﬂuorescent sterol rather than endogenous native
sterol (e.g. cholesterol) was considered. Although cholesterol is non-
ﬂuorescent, this possibility was tested by examining the uptake andlls. COS-7 cells were ﬁrst treated with Cy5-ACBP in the absence (not shown) or presence
membrane GM1-lipid rafts with Alexa Fluor488-cholera toxin B (at 4 °C, for 20 min), or
ds. (A) Overlay of Cy5-ACBP (blue), lipid raft marker (Alexa488-cholera toxin B, red) and
elected and shown inmagenta. (C) Bar graph of percent colocalization of Cy5-ACBP with
d) and nuclear marker (green) images. (E) Colocalized pixels of Cy5-ACBP and lysosome
5-ACBP and lysosome marker in cells treated with or without Pep-1.
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sterol dehydroergosterol (DHE). DHE exhibits high structural and
functional similarity to cholesterol and codistributes with cholesterol
in all membranes of the cell heretofore examined rev. in [16–20]. DHE
has proven useful to image intracellular cholesterol trafﬁcking by two-
photon laser scanning confocal microscopy [30,32,33].
COS-7 cells were labeled with DHE by preincubation with DHE/
POPC LUVs prior to incubation with TR-ACBP or Pep1/TR-ACBP as
described in Materials and methods. With increasing incubation time
DHE and TR-ACBP were taken up and distributed not only at the
plasma membrane but also throughout the cell as shown for DHE (Fig.
7A–C) and TR-ACBP (Fig. 7D–F). Merged MPLSM images of TR-ACBP
(green in Fig. 7G–I) and DHE (red in Fig. 7G–I) showed that, at early
time points little TR-ACBP appeared inside the cells, but was instead
distributed primarily at the plasma membrane (Fig. 7G). At longer
time points TR-ACBP was increasingly colocalized with DHE at the
plasma membrane and within cells as orange/yellow areas and also
some in the perinuclear region. Quantitative analysis of multiple
colocalized images showed that TR-ACBP/DHE colocalization coefﬁ-
cients were low, near 15% at early time points, but increased at longer
times to plateau near 75% colocalization (Fig. 7J). Interestingly, the
highest labeling of cells by TR-ACBP was observed within an area next
to nucleus, corresponding to Golgi complex, whichwas also labeled by
DHE. It has been previously demonstrated that DHE colocalized with
BODIPY-C5-ceramide (Golgi marker) in another cell type, namely L-
cells [32]. The data presented herein showed that DHE decorated COS-
7 cells within similar areas close to nuclei and TR-ACBP codistributed
with DHE in this region. Even if DHE was delivered by LUVs and 16 h
incubation with serum before addition of TR-ACBP±Pep-1, the Pep-1
had no signiﬁcant effect on the TR-ACBP colocalization with DHE (Fig.
7M). These data were consistent with Pep-1 not affecting theFig. 9. Colocalization of Cy5-ACBP with endoplasmic reticulum (ER) and mitochondrial mar
presence of Pep-1 in serum (for 30 min at 37 °C), then labeled with nuclear marker and eithe
andmethods). (A) Overlay of Cy5-ACBP (blue), nuclear marker (green) and ERmarker (red) im
magenta. (C) Bar graph of percent colocalization of Cy5-ACBP and ER marker in cells whic
mitochondrial marker (red) images in cells (treated with Pep-1). (E) Colocalized pixels of Cy5
Bar graph of percent colocalization of Cy5-ACBP and mitochondrial marker in cells in the aproportion of DHE-containing membrane/organelle associated vs
cytosolic TR-ACBP—conﬁrming results obtained with DChol.
3.7. Intracellular targeting of ﬂuorescent-labeled ACBP in live cells
We further examined the types of intracellular ﬂuorescent sterol-
containing organelles/membrane structures which were targeted by
TR-ACBP when it was delivered to cells by serum in the absence and
presence of Pep-1. Since most vital dye organelle markers emitted in
the same region as Texas Red, ACBP was labeled with Cy5 instead of
Texas Red. Similarly as for TR-labeling, Cy5-labeling did not or only
slightly altered ACBP structural and functional features (data not
shown). Therefore, COS-7 cells were ﬁrst incubated with Cy5-ACBP in
the absence or presence of Pep-1 for 1 h and then labeled with
ﬂuorescent vital dyemarkers for speciﬁc membrane-bound organelles
(plasma membrane, lysosomes, endoplasmic reticulum, mitochon-
dria) as described under Materials and methods. The nuclear marker
(Hoechst 33342) and the plasma membrane cholesterol-rich micro-
domain marker, Alexa Fluor 488-cholera toxin subunit B, did not
overlap signiﬁcantly with other intracellular organelle markers
examined (endoplasmic reticulum, mitochondria, lysosomes, Golgi).
However, due to the relative abundance of intracellular organelle
markers as well as the optical resolution of LSCM in the z-axis, there
was ∼10–15% overlap in distributions of the other intracellular
organelle markers (endoplasmic reticulum, mitochondria, lysosomes,
Golgi) with each other. Due to this overlap in organelle distributions,
the colocalization percentages obtained for the latter dyes represented
a relative colocalization of Cy5-ACBP with the lysosomal, mitochon-
drial, endoplasmic reticulum, and Golgi markers.
To determine the distribution of Cy5-ACBP to plasma membrane
cholesterol-rich microdomains in living cells, the Cy5-ACBP waskers in live cells. COS-7 cells were ﬁrst treated Cy5-ACBP in the absence (not shown) or
r ER or mitochondrial markers (for additional 30 min at 37 °C, as described in Materials
ages. (B) Colocalized pixels of Cy5-ACBP (blue) and ER (red) were selected and shown in
h were treated or not with Pep-1. (D) Overlay of Cy5-ACBP (blue), nuclei (green) and
-ACBP (blue) and mitochondrial marker (red) were selected and shown in magenta. (F)
bsence or presence of Pep-1.
Fig. 10. Colocalization of Cy5-ACBPwith Golgi and nuclearmarkers in live cells. COS-7 cells were ﬁrst treatedwith Cy5-ACBP in the absence (not shown) and presence of Pep-1 (30min
at s37 °C), then labeled with nuclear marker Hoechst 33342 and Golgi complexmarker, NBD-C6-ceramide (additional 30min at 37 °C, seeMaterials andmethods). (A) Overlay of Cy5-
ACBP (blue), Golgimarker (red) and nuclearmarker (green) in cells in the presence of Pep-1. (B) Colocalized pixels of Cy5-ACBP (blue in panel A) and Golgi marker (red in panel A)were
selected and shown here in magenta. (C) Colocalized pixels of Cy5-ACBP (blue in panel A) and nuclear marker (green in panel A) were selected and shown here in turquoise. (D) Bar
graph of percent colocalization of Cy5-ACBPwithGolgi complex in cells in the absence and presence of Pep-1. (E) Bar graph of percent colocalization of Cy5-ACBP and nuclearmarker in
cells in the absence and presence of Pep-1.
437A.D. Petrescu et al. / Biochimica et Biophysica Acta 1788 (2009) 425–441colocalized with Alexa Fluor 488-cholera toxin-B (CTB) which binds
with high afﬁnity to ganglioside GM1 in plasma membrane choles-
terol-rich microdomains [37]. COS-7 cells were ﬁrst pre-incubated
with Cy5-ACBP in the absence or presence of Pep-1 for 1 h at 37 °C,
and then labeled for GM1 with Alexa Fluor-CTB at 4 °C. As shown by a
representative overlay image of Cy5-ACBP (blue) and Alexa Fluor 488-
CTB cholesterol-rich microdomain marker (red), CTB was located
primarily at the plasma membrane (Fig. 8A) while ACBP was mostly
inside cells and only rarely in proximity with CTB-labeled lipid rafts.
When only colocalized pixels of Cy5-ACBP and Alexa Fluor 488-CTB
were shown (Fig. 8B, pink), Cy5-ACBP at the plasma membrane
appeared colocalized with cholesterol-rich microdomains at the
plasma membrane, exhibiting a discontinuous clustered distribution
therein. Calculated colocalization coefﬁcients estimated ∼18% of total
ﬂuorescent Cy5-ACBP colocalized with CT-B-488 cholesterol-rich
microdomain marker (Fig. 8C). The presence of Pep-1 during
incubation at 4 °C with Cy5-ACBP did not alter the extent (not
shown) or codistribution of Cy5-ACBP to plasma membrane choles-
terol-richmicrodomains (Fig. 8C). These data suggest that Cy5-ACBP is
more associated with cholesterol-rich microdomains at the plasma
membrane than with endocytosed cholesterol-rich microdomains
within the cell.
To show if Cy5-ACBP was also endocytosed via the lysosomal
pathway, co-distribution with LysoTracker was examined. An overlay
of respective images (Fig. 8D) showed lysosomal marker (red)
primarily in random punctuate distribution mostly separate from
Cy5-ACBP (blue). However, display of only colocalized pixels (Fig. 8E,
pink) and quantitative analysis of correlation coefﬁcients (Fig. 8F)
indicated that ∼24% of total Cy5-ACBP was colocalized with
LysoTracker, slightly higher than the ∼10–15% basal overlap of the
two other organellar markers (endoplasmic reticulum and mitochon-
dria shown below). Pep-1 did not affect co-distribution of Cy5-ACBPwith lysosomes (Fig. 8F). Thus, the majority (i.e. other than ∼9–14%
over basal overlap) of Cy5-ACBP was not colocalized with lysosomes,
consistent with ACBP primarily entering cells independently of the
endocytic/lysosomal pathway.
Colocalization of Cy5-ACBPwith endoplasmic reticulum (Fig. 9A–C)
and mitochondrial (Fig. 9D–F) was signiﬁcantly higher than basal.
Superposition of Cy5-ACBP (blue) with endoplasmic reticulum or
mitochondrial markers (red) demonstrated very different distribution
patterns. The endoplasmic reticulum marker was more diffusely
distributed within cytoplasm and exhibited thinner and more
numerousﬁne, net-like tubules, very heavily distributed inperinuclear
regions of the cells (Fig. 9A). In contrast, themitochondrial marker was
distributed in a more reticular, branched and conﬁned to well-deﬁned
tubular form pattern (Fig. 9D). The endoplasmic reticulum and
mitochondriamarkers werewidely distributed throughout cytoplasm,
resulting in considerable overlap of endoplasmic reticular and
mitochondria markers (data not shown). Colocalized pixels of Cy5-
ACBP with endoplasmic reticular marker (Fig. 9B) and mitochondrial
marker (Fig. 9E), respectively, indicate that a larger number of Cy5-
ACBP pixels colocalized with endoplasmic reticulum, especially in the
perinuclear region, than with mitochondrial marker. Quantitative
analysis indicated that∼63% of Cy5-ACBPwas colocalizedwith ER (Fig.
9C), while ∼46% colocalized withmitochondria (Fig. 9F). Pep-1 altered
this distribution, signiﬁcantly decreasing colocalization of Cy5-ACBP
with endoplasmic reticulummarker (63% vs 45%)while concomitantly
increasing codistribution with mitochondrial marker (46% vs 58%).
Colocalization images and analysis of ACBP with Golgi complex
and nuclearmarkers showed the highest colocalizationwith Golgi and
signiﬁcantly less colocalization with nuclei. Superposition of Cy5-
ACBP (blue) with Golgi (red) and nuclear (green) markers showed
colocalized pixels mainly with Golgi in the perinuclear area (Fig. 10A).
Display of colocalized pixels of Cy5-ACBP with Golgi (Fig. 10B, pink)
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Cy5-ACBP with Golgi, and a smaller but signiﬁcant overlap of Cy5-
ACBP with nuclei, especially near the nuclear envelope. Quantitative
analysis showed ∼70% of Cy5-ACBP colocalization with Golgi (Fig.
10D), but due to 10–15% overlap in distributions of Golgi, endoplasmic
reticulum, and mitochondrial markers, the actual colocalization is
near 55–60%. Finally, quantitative analysis showed ∼18% of TR-ACBP
colocalized with nuclei (Fig. 10E). Pep-1 had no effect on the relative
distribution of TR-ACBP to either Golgi or nuclei.
In summary, colocalization of Cy5-ACBP with vital dye markers of
intracellular organelles in living cells indicated that ACBPwas associated
with the intracellular membranous organelles in the following relative
order: Golgi≥endoplasmic reticulumNmitochondriaN lysosomes. Lesser
amounts of Cy5-ACBPwere also detected colocalizedwith cholesterol-
rich microdomains of the plasma membrane, and within nuclei.
3.8. Intracellular distribution of endogenous ACBP in ﬁxed cells: indirect
immunoﬂuorescence LSLCM
To test whether ACBP subcellular distribution determined by
using TR-ACBP or Cy5-ACBP and vital dye markers reﬂected that of
endogenous ACBP, intracellular distribution of endogenous ACBPFig. 11. Colocalization of ACBP with lipid raft, Golgi, lysosome, mitochondria, ER, and nuclear
of ﬁxed cells. (A) ACBP ﬂuorescence image. (B) Cholera toxin B (GM1-lipid rafts) ﬂuorescen
pixels in panel C were selected and shown in yellow. Inset: magniﬁcation of colocalized pix
(WGA-FITC). (F) ACBP with lysosomes (cathepsin). (G) ACBP with mitochondria (HSP70). (
33342).was examined by immunoﬂuorescence colocalization in ﬁxed T-7
rat hepatoma cells. These cells were chosen because, unlike COS-7
cells, the hepatoma cells express high levels of endogenous ACBP.
Hepatoma cells were ﬁxed and double immunolabeled as described
under Materials and methods. ACBP was colocalized with cholera
toxin B (GM1 marker in plasma membrane cholesterol-rich
microdomains), wheat germ agglutinin (WGA, Golgi marker), or
cathepsin D (lysosome marker) (Fig. 11). Endogenous ACBP was
distributed throughout the cells, with highest density in the
perinuclear cytoplasm and lower but distinct distribution within
nuclei and at the plasma membrane (Fig. 11A). Cholera toxin B
decorated GM1 in bright patches of cholesterol-rich microdomains
at the plasma membrane (Fig. 11B). The overlay of ACBP (red) and
cholera toxin B (green) images in T-7 hepatoma cells (Fig. 11C)
suggested signiﬁcant colocalization of ACBP and GM1-rich choles-
terol-rich microdomains in these cells. A computerized plot of only
colocalized pixels of ACBP and cholera toxin B (Fig. 11D, yellow)
conﬁrmed that ACBP was codistributed with GM1 in cholesterol-
rich microdomains at the plasma membrane. Panel D inset shows a
2.5 fold magniﬁcation of a plasma membrane region where ACBP
and cholera toxin marker were colocalized in a clustered, non-
random manner.markers in T-7 rat hepatoma cells by indirect immunoﬂuorescence confocal microscopy
ce image. (C) Overlay of ACBP (red) and cholera toxin B (green) images. (D) Colocalized
els along a portion of plasma membrane. (E) Colocalization of ACBP with Golgi marker
H) ACBP with endoplasmic reticulum (concanavalin A). (I) ACBP with nuclei (Hoechst
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intracellular organelle markers: First, a computerized plot of only
colocalized pixels of ACBP and Golgi complex marker (WGA, Golgi
marker) showed that ACBP codistributed strongly with WGA near the
nuclei (Fig. 11E, yellow). Second, ACBP colocalized less so with
lysosomes, especially near the cell periphery. Display of only
colocalized pixels of ACBP with lysosomes showed weak colocaliza-
tion in some cells, while other cells exhibited modest colocalization in
the most intensely stained regions (Fig. 11F, yellow). Third, display of
only colocalized pixels showed that endogenous ACBP also colocalized
with mitochondrial marker heat shock protein-70 (HSP70) to similar
extent as lysosomes, but in a more reticular pattern distributed in the
cytoplasm (Fig. 11G, yellow). Fourth, display of colocalized pixels of
ACBP with the endoplasmic reticulum marker (concanavalin A, ConA)
showed a high level of ACBP co-distribution in the perinuclear region
showing partial similarity in pattern as ACBP/Golgi (Fig. 11H, yellow).
Fifth, display of colocalized pixels of ACBP with nuclear DNA-binding
dye (Hoechst 33342) showed that ACBP was distributed within nuclei,
strongly at the nuclear envelope and in nuclear membrane invagina-
tions as well as more diffusely within nuclei (Fig. 11I, yellow). While
some ACBP pixels appeared colocalized with organelle markers in the
nuclear region, this was not due to the presence of these markers
within nuclei, but rather to LSCM resolution in the z-axis and cell
thinning in response to dehydration during the ﬁxation process — a
problem much less associated with LSCM of living cells.
Quantitative estimations by colocalization coefﬁcient analysis
indicated that endogenous ACBP in ﬁxed rat hepatoma cells was
distributed with the above intracellular organelle markers in the
following order: Golgi≥endoplasmic reticulumNmitochondriaN lyso-
some. ACBP was also detected in cholesterol-rich microdomains of the
plasma membrane and within nuclei. Thus, immunoﬂuorescence
LSCM examination and colocalization analysis of ACBP in a cell line
with high endogenous ACBP expression paralleled the results obtained
with Cy5- ACBP and vital dye organelle markers in live COS-7 cells.
4. Discussion
While most studies of CPP mediated protein transduction have
focused on mechanism(s) of uptake into the cell, little is known
regarding the relative amount of cargo protein that subsequently
emerges free in the cytoplasm for distribution to appropriate
intracellular targets similar to endogenous cargo protein. The current
investigation presented for the ﬁrst time the use of ﬂuorescent sterols
(DChol, DHE) as markers for determining the relative proportion of
cargo protein free in cytosol/nucleoplasmvs associatedwith endocytic
vesicles/organellemembranes. For these studies ACBPwas chosen as a
cargo protein because: (i) ACBP is a ubiquitous intracellular protein
expressed in most tissues/cells; (ii) ACBP is soluble in the cytosol as
well as associated with select membranes/organelles; (iii) ACBP is
sufﬁciently small (10 kDa) to pass through nuclear pores to enter the
nucleoplasm wherein it directly interacts with nuclear receptors
[22,38]. Since endocytosed vesicles are too large to pass through
nuclear pores, the appearance of ACBP in the nucleoplasm provides
another measure of exit of exogenously added ACBP from endocytic
vesicles. These studies yielded several new insights:
First, real-time laser scanning microscopy (LSCM, MPLSM) of
ﬂuorescent sterols (DChol, DHE) showed these sterols were distrib-
uted in plasma membranes, plasma membrane cholesterol-rich
microdomains, endocytic vesicles, and intracellular organelles/mem-
branes in living cells. The data showed DChol as a brightly-ﬂuorescent,
synthetic sterol readily visualized by LSCM both at the plasma
membrane and intracellular membranes of living COS-7 cells. Similar
ﬁndings were obtained with DHE (a low quantum yield, naturally-
occurring ﬂuorescent sterol readily visualized by MPLSM) in COS-7
cells — consistent with MPLSM imaging of DHE in L-cell ﬁbroblasts
[32,33]. The real-time imaging studies were also supported by theresults of subcellular fractionation and chemical analysis which
showed that: (i) DHE codistributes with cholesterol in plasma
membranes of cultured (L-cell, MDCK) cells [39,40], signiﬁcantly
more with cholesterol-rich than –poor microdomains [41–44]; (ii)
DHE codistributes with cholesterol in intracellular membranes such as
mitochondria [39,45], endoplasmic reticulum [39], and lysosomes
[46] of cultured L-cell ﬁbroblasts. Finally, the membrane distributions
of DChol and DHE reﬂected those of cholesterol which is present in all
cellular membranes with the exception of the inner mitochondrial
membrane (rev. in [16,17,20]. Thus, the ﬂuorescent sterols provided a
novel means for real-time imaging of spontaneous and CPP-mediated
protein cargo transduction, exit from endocytic uptake, and intracel-
lular redistribution within the cell.
Second, the ﬂuorescent sterols were useful as markers of endocytic
uptake pathways in living cells. DChol colocalized with plasma
membrane specialized domains labeled by cholera toxin B which
binds to GM1 ganglioside in cholesterol-rich microdmains suggesting
uptake via GM 1 cholesterol-rich microdomain-related pathways.
Even though GM1 was ﬁrst reported to be located in caveolae, more
recent reports indicate that GM1 can also be associated with
cholesterol-rich microdomains in macropinocytosis compartments
[47–49]. Cholesterol-rich microdomain-associated GM1 was selec-
tively included into macropinosomes [49]. The intracellular uptake of
cholesterol from serum (containing LDL, HDL) also occurs by
endocytosis pathways including: i) LDL-receptor mediated endocy-
tosis through clathrin-coated vesicles [50]; ii) HDL-receptor, SR-BI-
mediated uptake/efﬂux at the caveolae level [51]; iii) receptor-
independent uptake of LDL by ﬂuid phase or macropinocytosis [52].
In the present study, DChol was shown to colocalize with markers for
the clathrin-mediated endosomal/lysosomal pathway (Transferrin)
and nearly twice as much with the macropinocytosis pathway (TR-
dextran) — consistent with high codistribution of DChol with CT-B
(marker for GM1 in cholesterol-rich microdomains). Thus, DChol was
similar to naturally-ﬂuorescent sterol DHE in that DChol was not
highly associated with the clathrin-coated pit endocytic unless the
sterol was crystalline in the medium [32,46].
Third, Pep-1 enhanced ACBP translocation into COS-7 cells by 2.4-
fold via pathways similar to those employed for DChol uptake, i.e.
mostly macropinocytosis and less so clathrin-mediated endocytosis.
Pep-1 is known to enhance the rate of macropinocytosis of other types
of cargo protein [53]. The enhancing effect of Pep-1 upon macro-
pinocytosis-mediated uptake of TR-ACBP and colocalization with
DChol was abolished when DChol was delivered to cells by methyl-β-
cyclodextrin (data not shown). This ﬁnding was consistent with the
reported ability of cyclodextrin to interfere with cholesterol in
cholesterol-rich microdomains and to inhibit macropinocytosis [53].
Fourth, TR-ACBP was translocated into COS-7 cells even in the
absence of Pep-1, albeit 2.4-fold less efﬁciently. This ﬁnding might be
explained by at least two possibilities: (i) The presence of a CPP-like
domain in ACBP itself. The amino acid sequence of mouse ACBP has
several putative NLS (nuclear localization signals which are char-
acteristic for CPPs) domains (e.g. LKKKYGI with three lysine residues
grouped together at the C-end of the molecule; VKRLKT with two
lysines and an arginine in close proximity), but these sequences do not
contain hydrophobic residues to enforce interaction with phospholi-
pid membranes. However, an additional basic and hydrophobic amino
acid-rich domain (a.a. 50–65) comprised of LKGKAKWDSWNKLKGT
contains 5 lysine (K) residues alternating with two tryptophans (W)
which might resemble the structure of a CPP such as Pep-1. (ii) Serum
components that facilitate macropinocytic uptake of plasma mem-
brane bound ACBP. ACBP is known to bind to anionic phospholipid
containing but not neutral charged phospholipid containing model
membranes [54,55]. Serum contains fetuin/alpha2-HS glycoprotein
which has been shown to increase the uptake of dextran by cells
through macropinocytosis [56]. Interestingly, extraction of cholesterol
from cellular plasma membranes inhibited macropinosomes by
440 A.D. Petrescu et al. / Biochimica et Biophysica Acta 1788 (2009) 425–441disrupting cholesterol-rich microdomains and by negatively affecting
actin organization and small GTP-ase Rac-1 activity, which were
demonstrated to be involved in macropinosome formation [57]. Taken
together these data suggested that the basic amino acid-rich domains
in ACBP were insufﬁcient to induce ACBP translocation into COS-7
cells, but together with serum components this uptake was facilitated
even in the absence of CPP such as Pep-1.
Fifth, a signiﬁcant portion TR-ACBP translocated into COS7 cells
entered the cytoplasm. About 20–40% of TR-ACBP taken up was not
colocalized with DChol containing vesicles/organelle membranes and
appeared free in the cytosol/nucleoplasm. With regards to the
membrane component, TR-ACBP taken up by endocytosis was
distributed similarly as endogenous ACBP to Golgi≥endoplasmic
reticulumNmitochondriaN lysosomeNplasma membrane cholesterol-
rich microdomains, and nuclei. ACBP colocalization with endoplasmic
reticulum of living cells was consistent with its role in facilitating
transacylation steps in fatty acid esteriﬁcation to cholesteryl esters
and glycerophospholipid (phosphatidic acid) [58,59]. Likewise, ACBP
colocalization with mitochondria of living cells suggested that ACBP
may also enhance transfer of bound long chain fatty acyl CoA to
carnitine palmitoyl transferase I (CPT1), the rate limiting enzyme in
mitochondrial fatty acid oxidation, located at the outer mitochondrial
membrane [60,61]. Consistent with this possibility, ACBP enhances the
activity of CPT1 in vitro [60,61]. Finally, appearance of ACBP in nuclei
of living cells was consistent with earlier ﬁxed cell experiments
detecting ACBP in nuclei and with studies showing that ACBP
overexpression transactivates nuclear transcription factors such as
HNF4α [22,62]. Finally, detection of TR-ACBP in nuclei and nucleo-
plasm of living cells provides an important control indicating that the
TR-ACBP was released from endocytic vesicles for transport into the
nucleoplasm. Pores in the nuclear envelope double membrane are
sufﬁciently large to accommodate small proteins such as ACBP
(10 kDa), but not endocytic vesicles (rev. in [21]).
Sixth, Pep-1 selectively altered the intracellular targeting/dis-
tribution of ACBP without altering the proportion that membrane
associated vs cytosolic/nucleoplasmic. Since Pep-1 enhanced uptake
of TR-ACBP by 2.4-fold, this was consistent with the majority of TR-
ACBP exiting endocytic compartment(s). Further consistent with this
ﬁnding was the fact that Pep-1 facilitated colocalization of ACBP
with mitochondria, reduced colocalization with endoplasmic reticu-
lum, but did not alter colocalization with plasma membrane cho-
lesterol-rich microdomains, lysosomes, or nuclei. While the
molecular basis for this observation remains to be resolved, it may
relate to channeling of cargo protein taken up by different endocytic
mechanisms.
In summary, the work presented herein showed for the ﬁrst time
that the ﬂuorescent sterols (DChol, DHE) were useful markers for
comparing the membrane/organelle vs soluble (cytosol, nucleoplasm)
distributions of both exogenous translocated and endogenous
proteins. While Pep-1 did not alter the relative proportions of
membrane vs cytosol/nucleoplasm associated TR-ACBP, the transloca-
tion of TR-ACBP into living cells was modestly increased 2.4-fold. In
addition, Pep-1 altered the intracellular targeting of exogenous-
delivered (TR-ACBP) by shifting TR-ACBP distribution away from
endoplasmic reticulum toward mitochondria.
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